Birchview Capital’s Xenon Pharmaceuticals XENE Stock Holding History

Birchview Capital’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.22M	Hold	21,000	–	–	0.7%	37
2025 Q4	$941K	Hold	21,000	–	–	0.55%	40
2025 Q3	$843K	Hold	21,000	–	–	0.64%	40
2025 Q2	$657K	Hold	21,000	–	–	0.65%	34
2025 Q1	$705K	Buy	21,000 +11,000	+110%	+$418K	0.61%	26
2024 Q4	$392K	Hold	10,000	–	–	0.32%	39
2024 Q3	$394K	Hold	10,000	–	–	0.34%	34
2024 Q2	$390K	Hold	10,000	–	–	0.36%	37
2024 Q1	$431K	Hold	10,000	–	–	0.35%	37
2023 Q4	$461K	Hold	10,000	–	–	0.36%	35
2023 Q3	$342K	Hold	10,000	–	–	0.29%	37
2023 Q2	$385K	Hold	10,000	–	–	0.29%	38
2023 Q1	$358K	Hold	10,000	–	–	0.28%	37
2022 Q4	$394K	Hold	10,000	–	–	0.28%	38
2022 Q3	$361K	Hold	10,000	–	–	0.25%	45
2022 Q2	$304K	Buy	+10,000	New	+$302K	0.22%	46

Other funds holding XENE

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return